Test an AI score to guide liver transplant decisions
Part of Cancer, Digestive system clinical trials.
This study looks at a prediction tool that estimates outcomes for people with liver cancer and cirrhosis, to help decide whether a liver transplant is a good option. It may help doctors choose the right timing and patients who could benefit most from transplantation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cancer (hepatocellular carcinoma) along with cirrhosis
- You are between 18 and 70 years old
- Your total tumor size is under 500 cubic centimeters (cm³)
- You have fewer than 10 tumor spots (lesions)
- Your largest single tumor is under 10 centimeters across
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI tool to predict how liver cancer might come back after surgery. It is for people with early-stage liver cancer who are already scheduled for surgery and have recent MRI scans.
This study uses different scoring systems to predict how well patients with cirrhosis will do while waiting for a liver transplant. It helps doctors understand which patients are most likely to benefit from the transplant.
This study uses artificial intelligence to analyze CT scans before and during liver surgery. It aims to build a decision-making system to help doctors better plan and perform surgery for liver cancer or other growths.
This study compares an artificial intelligence tool against a standard liver scan scoring system (LI-RADS) to diagnose liver cancer (HCC) on CT scans. It may help make liver cancer detection more accurate for people at higher risk.
This trial uses artificial intelligence to help doctors better stage (classify the severity of) and plan treatment for hepatocellular carcinoma, a type of primary liver cancer. Researchers will collect your clinical information and imaging to see if AI can improve decision-making about your care.
This study looks at how well the HepatoPredict tool predicts outcomes for people with liver cancer who had a liver transplant or surgery to remove the tumor. The researchers are checking if the tool was accurate by reviewing data from at least 5 years after the procedure.
Hear when a new Recurrence Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.